Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

P21 Peptide vs p21 Protein: Full Comparison

Molecular Weight ~2.4 kDa (23 amino acids) ~21 kDa (164 amino acids) P21 peptide is 8–9× smaller; crosses BBB readily Primary Mechanism NGF pathway activation, hippocampal neurogenesis CDK inhibition, cell cycle arrest at G1/S checkpoint Entirely different bio

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Molecular Weight
  • ~2.4 kDa (23 amino acids)
  • ~21 kDa (164 amino acids)
  • P21 peptide is 8–9× smaller; crosses BBB readily
  • Primary Mechanism
  • NGF pathway activation, hippocampal neurogenesis
  • CDK inhibition, cell cycle arrest at G1/S checkpoint
  • Entirely different biological roles
  • Research Applications
  • Cognitive enhancement, neuroprotection, traumatic brain injury recovery
  • Tumour suppression, DNA damage response, senescence studies
  • Administration Route
  • Intranasal (preferred), subcutaneous
  • In vitro assays, recombinant protein for cell culture
  • P21 peptide designed for in vivo CNS delivery
  • Storage (Lyophilised)
  • −20°C, reconstitute in bacteriostatic water
  • −80°C as recombinant liquid in glycerol buffer
  • Different stability profiles
  • Gene/Origin
  • Synthetic analogue of CNTF amino acid segment
  • Encoded by CDKN1A gene (human chromosome 6)
  • Peptide is fully synthetic; protein is naturally occurring